BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2942650)

  • 1. Distribution of hematoporphyrin derivative in canine glioma following intraneoplastic and intraperitoneal injection.
    Steichen JD; Dashner K; Martuza RL
    J Neurosurg; 1986 Sep; 65(3):364-9. PubMed ID: 2942650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution, retention, and phototoxicity of hematoporphyrin derivative in a rat glioma. Intraneoplastic versus intraperitoneal injection.
    Kostron H; Bellnier DA; Lin CW; Swartz MR; Martuza RL
    J Neurosurg; 1986 May; 64(5):768-74. PubMed ID: 2939204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of hematoporphyrin derivative into rat brain and intracerebral 9L glioma tissue.
    Boisvert DP; McKean JD; Tulip J; Cummins J; Cheng MK
    J Neurooncol; 1985; 3(2):113-8. PubMed ID: 3162004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observations in studies of quantitative kinetics of tritium labelled hematoporphyrin derivatives (HpDI and HpDII) in the normal and neoplastic rat brain model.
    Little FM; Gomer CJ; Hyman S; Apuzzo ML
    J Neurooncol; 1984; 2(4):361-70. PubMed ID: 6241630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake and retention of hematoporphyrin derivative in an in vivo/in vitro model of cerebral glioma.
    Kaye AH; Morstyn G; Ashcroft RG
    Neurosurgery; 1985 Dec; 17(6):883-90. PubMed ID: 2934641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective uptake of hematoporphyrin derivative into human cerebral glioma.
    Hill JS; Kaye AH; Sawyer WH; Morstyn G; Megison PD; Stylli SS
    Neurosurgery; 1990 Feb; 26(2):248-54. PubMed ID: 2137904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of hematoporphyrin derivative to brain tumor cells--a fluorescence spectroscopic study.
    Joshi K; Joshi PG; Joshi NB
    Photochem Photobiol; 1992 Jan; 55(1):113-8. PubMed ID: 1534907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue.
    Gomer CJ; Dougherty TJ
    Cancer Res; 1979 Jan; 39(1):146-51. PubMed ID: 761185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-tumor effect of hyperthermia plus hematoporphyrin derivative on malignant brain tumor].
    Hondo H
    No To Shinkei; 1988 May; 40(5):477-84. PubMed ID: 3415865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Components of hematoporphyrin derivatives and their tumor-localizing capacity.
    Kessel D
    Cancer Res; 1982 May; 42(5):1703-6. PubMed ID: 7066890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of route of administration on the selectivity of hematoporphyrin derivative for tumor tissue.
    Elmer EB; Wood WC; Cohen AM; Bamberg M
    J Surg Oncol; 1987 Feb; 34(2):113-9. PubMed ID: 2949116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of hematoporphyrin derivative in the rat 9l gliosarcoma brain tumor analyzed by digital video fluorescence microscopy.
    Boggan JE; Walter R; Edwards MS; Borcich JK; Davis RL; Koonce M; Berns MW
    J Neurosurg; 1984 Dec; 61(6):1113-9. PubMed ID: 6239014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Selective hematoporphyrin derivative (HMD) application in arterial vessels using a porous balloon catheter results in equivalent levels as compared to high-dose systemic administration].
    Gonschior P; Erdemci A; Gerheuser F; Gonschior GM; Mack B; Kolbe T; Goetz AE; Höfling B
    Z Kardiol; 1991 Dec; 80(12):738-45. PubMed ID: 1837968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse.
    Bugelski PJ; Porter CW; Dougherty TJ
    Cancer Res; 1981 Nov; 41(11 Pt 1):4606-12. PubMed ID: 7306978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-localizing and photosensitizing properties of hematoporphyrin derivative in hamster buccal pouch carcinoma.
    Burns RA; Klaunig JE; Shulok JR; Davis WJ; Goldblatt PJ
    Oral Surg Oral Med Oral Pathol; 1986 Apr; 61(4):368-72. PubMed ID: 2939386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hematoporphyrin derivative photoradiation therapy on survival in the rat 9L gliosarcoma brain-tumor model.
    Boggan JE; Bolger C; Edwards MS
    J Neurosurg; 1985 Dec; 63(6):917-21. PubMed ID: 2932542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of 28 porphyrins and their abilities to localize in mammary mouse carcinoma: uroporphyrin I superior to hematoporphyrin derivative.
    El-Far M; Pimstone N
    Prog Clin Biol Res; 1984; 170():661-72. PubMed ID: 6241706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematoporphyrin derivative photoradiation therapy of the rat 9L gliosarcoma brain tumor model.
    Boggan JE; Edwards MS; Berns MW; Walter RJ; Bolger CA
    Lasers Surg Med; 1984; 4(1):99-105. PubMed ID: 6235423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy of intraocular tumors: examination of hematoporphyrin derivative distribution and long-term damage in rabbit ocular tissue.
    Gomer CJ; Jester JV; Razum NJ; Szirth BC; Murphree AL
    Cancer Res; 1985 Aug; 45(8):3718-25. PubMed ID: 4016749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoradiation therapy causing selective tumor kill in a rat glioma model.
    Kaye AH; Morstyn G
    Neurosurgery; 1987 Mar; 20(3):408-15. PubMed ID: 2952899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.